Lung Cancer

American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends

By

Rachel Narozniak, MA

Publish Date February 8, 2021

The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.

Racial Disparities in Lung Cancer: Part 2 of a Special Series

By

Tori Rodriguez, MA, LPC, AHC

Publish Date January 12, 2021

In part 2 of this 3-part series, the recent State of Lung Cancer report by the American Lung Association, which included state-level and national-level data on lung cancer in people of color for the first time.

Racial Disparities in Lung Cancer: Part 1 of a Special Series

By

Tori Rodriguez, MA, LPC, AHC

Publish Date January 8, 2021

A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.

Reduced-Dose CT Comparable to Standard CT for Detecting Lung Nodules in Younger Patients

Researchers sought to determine the effectiveness of reduced-dose CT for detection and monitoring of lung nodules in pediatric and young adult patients.

Less Than Half of NSCLC Patients Received Comprehensive Biomarker Testing in a Real-World Study

Most patients had at least 1 biomarker test, but only 46% had all 5 biomarker tests.

Study Suggests Possible Fix for Gender Disparity in the 2021 US Preventative Services Task Force Guidelines

Adding PLCOm2012 criteria to 2021 USPSTF guidelines could increase lung cancer screening in women.

Pembrolizumab Provides Durable Survival Benefit in Metastatic Non-Small Cell Lung Cancer With High PD-L1 Expression

The 5-year survival rate was superior with pembrolizumab.

Savolitinib May Be Effective in Treating Pulmonary Sarcomatoid Carcinoma

Researchers assessed the safety of savolitinib in patients with pulmonary sarcomatoid carcinoma and other NSCLC subtypes positive for METex14-positive.